Sincere gratitude to Dr Bent Jakobsen for his efforts in supporting Continuum over the past months.
Continuum Life Sciences would like to express their sincere gratitude to Dr Bent Jakobsen for his efforts in supporting Continuum over the past months. We wish him every success in his numerous ventures.
We welcome Mr Alan Whiteley as interim CEO.
Continuum now enters an extremely exciting phase of its development including the opening of a bespoke, state of the art Oxfordshire laboratory, where we will further develop exciting discoveries.
We are also looking forward to the appointment of a full time Chief Scientific Officer to reinforce our current science team and further advance our strategy. The new CSO will work in parallel to develop the unique Continuum Cancer Survivor Cohort.